Ray Dalio
ADMA icon

Ray Dalio’s ADMA Biologics ADMA Stock Holding History

Ray Dalio’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.36M Sell
401,059
-71,049
-15% -$648K 0.01% 570
2026
Q1 		$4.25M Buy
472,108
+285,637
+153% +$4.51M 0.02% 458
2025
Q4 		$3.4M Buy
186,471
+126,189
+209% +$2.13M 0.01% 636
2025
Q3 		$884K Buy
+60,282
New +$1.03M ﹤0.01% 863

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Caligan Partners
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Ray Dalio's ADMA Position: Q2 2026 in Review

Ray Dalio reduced its ADMA Biologics (ADMA) stake by 15% in Q2 2026, selling an estimated $648K and leaving 401,059 shares worth $3.36M. The position accounts for 0.01% of the portfolio, ranked #570.

Ray Dalio first reported a position in ADMA in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.25M in Q1 2026. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Ray Dalio held 401,059 shares of ADMA Biologics worth $3.36M as of Q2 2026.
  • Ray Dalio sold 71,049 ADMA Biologics shares in Q2 2026, an estimated $648K.
  • ADMA Biologics made up 0.01% of Ray Dalio's portfolio in Q2 2026, its #570 holding.
  • Ray Dalio first reported a position in ADMA Biologics in Q3 2025 and has held it in 4 quarters since.
  • Ray Dalio's ADMA Biologics position peaked at $4.25M in Q1 2026.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.